Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Summers

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
The Journal of Physiology|March 22, 2016
Rebuttal from Scott A. Summers and Bret H. GoodpasterScott A Summers, Bret H Goodpaster
The Journal of Clinical Investigation|November 3, 2011
Ceramides as modulators of cellular and whole-body metabolismBenjamin T Bikman, Scott A Summers
Nature Reviews. Endocrinology|November 4, 2016
Sphingolipids and phospholipids in insulin resistance and related metabolic disordersPeter J Meikle, Scott A Summers
Archives of Biochemistry and Biophysics|November 1, 2003
Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubesJose Antonio Chavez, Scott A Summers
Diabetes|March 1, 2005
A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndromeScott A Summers, Don H Nelson
The Journal of Physiology|March 22, 2016
CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistanceScott A Summers, Bret H Goodpaster
Biochimica Et Biophysica Acta|October 3, 2009
Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanismsJose Antonio Chavez, Scott A Summers
Frontiers in Endocrinology|August 28, 2020
Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLDAnnelise M Poss, Scott A Summers
Endocrine Reviews|May 3, 2008
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolismWilliam L Holland, Scott A Summers
Cell Metabolism|May 8, 2012
A ceramide-centric view of insulin resistanceJose A Chavez, Scott A Summers
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
The Journal of Physiology|March 22, 2016
Rebuttal from Scott A. Summers and Bret H. GoodpasterScott A Summers, Bret H Goodpaster
The Journal of Clinical Investigation|November 3, 2011
Ceramides as modulators of cellular and whole-body metabolismBenjamin T Bikman, Scott A Summers
Nature Reviews. Endocrinology|November 4, 2016
Sphingolipids and phospholipids in insulin resistance and related metabolic disordersPeter J Meikle, Scott A Summers
Archives of Biochemistry and Biophysics|November 1, 2003
Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubesJose Antonio Chavez, Scott A Summers
Diabetes|March 1, 2005
A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndromeScott A Summers, Don H Nelson
The Journal of Physiology|March 22, 2016
CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistanceScott A Summers, Bret H Goodpaster
Biochimica Et Biophysica Acta|October 3, 2009
Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanismsJose Antonio Chavez, Scott A Summers
Frontiers in Endocrinology|August 28, 2020
Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLDAnnelise M Poss, Scott A Summers
Endocrine Reviews|May 3, 2008
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolismWilliam L Holland, Scott A Summers
Cell Metabolism|May 8, 2012
A ceramide-centric view of insulin resistanceJose A Chavez, Scott A Summers
Pageof 14